Tumor Markers CA 19-9 and CA 50 in Liver Cancers
Author Information
Author(s): C. Haglund, J. Lindgren, P.J. Roberts, S. Nordling
Primary Institution: Helsinki University Central Hospital
Hypothesis
The study investigates the expression of tumor markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
Conclusion
Hepatocellular carcinomas do not express CA 19-9 and CA 50, while most cholangiocarcinomas do, which may aid in their differential diagnosis.
Supporting Evidence
- CA 19-9 and CA 50 are normal constituents of bile ducts.
- Cholangiocarcinomas showed a high positivity for CA 19-9 and CA 50.
- Hepatocellular carcinomas did not express CA 19-9 or CA 50.
Takeaway
This study looked at two markers in liver cancer and found that one type of cancer shows them while the other does not, helping doctors tell them apart.
Methodology
The study used immunoperoxidase staining on formalin-fixed, paraffin-embedded tissue sections from liver cancer specimens.
Limitations
The study does not address the potential for other gastrointestinal tumors to express these markers.
Want to read the original?
Access the complete publication on the publisher's website